Measurement of estrogens, androgens, and progestagens in an expanded case-control study of breast cancer nested in the plco cohort.

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700602P
Awardee
Awarding agency
Obligated
$149,100

Award facts

Opportunity
Contract value 100% obligated
$149,100.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
B529 Special Studies/Analysis- Scientific Data
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30303, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to the National Foundation For The Centers For Disease Control & Prevention, Inc. (CDC Foundation) valued at $149,100 on September 18, 2017, for measurement of estrogens, androgens, and progestagens in an expanded case-control study of breast cancer nested in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cohort. The work is performed in Atlanta, Georgia under a firm fixed price contract with an ultimate completion date of September 17, 2018.

Quick answers

Who was awarded contract HHSN261201700602P?

HHSN261201700602P was awarded to National Foundation For The Centers For Disease Control & Prevention, Inc. by National Cancer Institute (National Institutes of Health) on September 18, 2017.

How much is contract HHSN261201700602P worth?

The government has obligated $149,100 on HHSN261201700602P.

Was contract HHSN261201700602P competed?

The extent of competition for HHSN261201700602P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award